ADDICTION AND PAIN MANAGEMENT

• New FDA guidelines for naloxone use
• Treating acute and chronic pain in patients with substance use disorder 
• Managing complicated alcohol withdrawal
• Alcoholic hallucinosis in the inpatient setting: is haloperidol safe?
• Reducing the risk of recurrent opiate overdose at discharge

ALLERGY

• What to do when there is no allergist
• Penicillin allergy: a risk factor for inferior antibiotic treatment
• Getting rid of the low-risk penicillin allergy label 
• New anaphylaxis guidelines

CARDIOVASCULAR

• Dual anti-platelet therapy after stenting: are we overdoing it?
• Rethinking rhythm control versus rate control for atrial fibrillation
• Peri-operative anticoagulation in patients on DOACs
• Post-op atrial fibrillation: to anticoagulate, or not to anticoagulate?
• CHA₂DS₂-VASc: more than just a number?
• SGLT-2 inhibitors: a new standard for CHF treatment
• New data on the benefits of IV iron in heart failure
• Overcoming diuretic resistance in heart failure
• Is it ever OK to stop anticoagulation in unprovoked venous thrombosis?
• When to refer patients with aortic stenosis for TAVR

DELIRIUM

• Update on pharmacotherapy for delirium
• Reducing delirium complications: is a bedside companion key?
• Hospital-acquired delirium: a risk factor for dementia
• Difficult cases in delirium management

DIAGNOSTICS

• Can't-miss ECG diagnoses
• Radiology pearls: identifying subtle findings on CXR
• Rapid-fire review of electrolyte, liver, and heme cases
• Contrast or no contrast? Choosing the right imaging protocols

ENDOCRINE

• Hyperglycemia in the setting of COVID cytokine storm
• Dangers of SGLT2 inhibitors: euglycemic DKA and UTIs
• Challenging cases in insulin management
• Best practices for hyperglycemic crises

GASTROINTESTINAL

• COVID-19 and the GI tract
• New risk scores for GI bleeding
• Time to rethink the "GI cocktail?"
• Urgent endoscopy in acute GI bleeding: bad for patients?
• Managing bleeding and thrombosis in the cirrhotic patient
• Too soon? Resuming anticoagulation and antiplatelet agents after a GI bleed
• New data on the management of upper GI bleeding

HEMATOLOGIC

• DOACs for cancer-associated venous thrombosis
• DOAC use in obesity and kidney disease
• Diagnosing and managing thrombocytopenia
• Approach to anemia in the hospitalized patient
• The latest on COVID-associated arterial and venous thrombosis

INFECTIOUS DISEASES

• Long live the fecal microbiota transplant!
• New strategies to prevent recurrent cellulitis
• New antibiotics for MRSA and highly-resistant gram-negative rods
• Are we underdosing beta-lactams in the critically ill?
• The latest data on COVID-19 vaccines
• Risks for COVID-19 in healthcare workers and their families
• High rates of asymptomatic COVID-19 in nursing home patients
• SARS-CoV-2 mutations: what are the clinical implications?
• Corticosteroids in COVID-19
• Evidence-based treatment for COVID-19: what actually works?
• SARS-CoV-2 reinfection: what does it mean for hospitalists?
• Intensive case-based review of inpatient antibiotic therapy
• New antibiotics for complicated UTIs
• Pearls for interpreting culture and sensitivity data

PALLIATIVE CARE

• Palliative care in end-stage COPD
• Alternatives to the 10-point pain scale
• Case-based approach to the complex palliative care patient
• What time is the right time to call palliative care?

PERIOPERATIVE MEDICINE

• Should we use BNP to predict perioperative risk?
• The latest on perioperative aspirin, statins, beta-blockers, and ACE inhibitors
• Perioperative anticoagulation: when should patients be bridged?
• Timing of surgery in hip fracture patients
• Reducing pulmonary risk in perioperative patients

PULMONARY

• Non-invasive ventilation in COPD: new guidelines
• State of the art treatment for asthma and COPD exacerbations
• Current recommendations for high-flow and supplemental O₂
• Are C-reactive protein and procalcitonin useful in COPD and pneumonia management?

RENAL

• Dapagliflozin and reduction of progression of chronic kidney disease
• New data: early renal replacement therapy in acute kidney injury
• COVID and acute kidney injury: what the hospitalist needs to know
• Dialysis access: what the hospitalist needs to know
• Blood pressure management in end-stage renal disease
• The latest on managing hyperkalemia and hyperphosphatemia
• Diagnosing acute kidney injury and acute glomerulonephritis

STROKE

• New AHA/ASA guidelines for stroke management
• Updates on mechanical thrombectomy for ischemic stroke
• The unexpected dangers of SSRIs in acute stroke
• Anti-platelet therapy in stroke and TIA

SYNCOPE

• Syncope: when to worry about cardiac causes
• New recommendations for the use of tilt table testing
• Syncope as a presenting symptom of COVID
• Diagnosing the patient with recurrent syncope